Irène Feroce

1.2k total citations
33 papers, 521 citations indexed

About

Irène Feroce is a scholar working on Genetics, Molecular Biology and Pathology and Forensic Medicine. According to data from OpenAlex, Irène Feroce has authored 33 papers receiving a total of 521 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Genetics, 12 papers in Molecular Biology and 9 papers in Pathology and Forensic Medicine. Recurrent topics in Irène Feroce's work include BRCA gene mutations in cancer (14 papers), Genetic factors in colorectal cancer (7 papers) and Estrogen and related hormone effects (7 papers). Irène Feroce is often cited by papers focused on BRCA gene mutations in cancer (14 papers), Genetic factors in colorectal cancer (7 papers) and Estrogen and related hormone effects (7 papers). Irène Feroce collaborates with scholars based in Italy, United Kingdom and United States. Irène Feroce's co-authors include Bernardo Bonanni, Sara Gandini, Monica Barile, Patrick Maisonneuve, Paolo Radice, Simona Iodice, Aliana Guerrieri‐Gonzaga, Loris Bernard, Nicole Rotmensz and Davide Serrano and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Irène Feroce

30 papers receiving 505 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Irène Feroce Italy 12 244 152 119 102 101 33 521
Jeanna McCuaig Canada 14 320 1.3× 103 0.7× 158 1.3× 101 1.0× 139 1.4× 39 490
Luna Kaduri Israel 10 308 1.3× 194 1.3× 133 1.1× 68 0.7× 88 0.9× 13 656
Ingrid Slade United Kingdom 9 238 1.0× 132 0.9× 106 0.9× 47 0.5× 72 0.7× 10 431
Rochelle Demsky Canada 13 458 1.9× 103 0.7× 231 1.9× 246 2.4× 101 1.0× 25 686
Kristen J. Vogel United States 13 231 0.9× 100 0.7× 125 1.1× 25 0.2× 100 1.0× 19 430
Robin A. Lacour United States 11 199 0.8× 76 0.5× 182 1.5× 195 1.9× 114 1.1× 21 579
Michaela Onstad United States 10 83 0.3× 158 1.0× 304 2.6× 145 1.4× 177 1.8× 24 736
Douglas F. Easton United Kingdom 5 421 1.7× 159 1.0× 325 2.7× 33 0.3× 145 1.4× 8 671
M. Daly United States 6 644 2.6× 184 1.2× 204 1.7× 183 1.8× 189 1.9× 7 802
Simona Moroni Italy 16 162 0.7× 71 0.5× 180 1.5× 328 3.2× 84 0.8× 20 665

Countries citing papers authored by Irène Feroce

Since Specialization
Citations

This map shows the geographic impact of Irène Feroce's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Irène Feroce with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Irène Feroce more than expected).

Fields of papers citing papers by Irène Feroce

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Irène Feroce. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Irène Feroce. The network helps show where Irène Feroce may publish in the future.

Co-authorship network of co-authors of Irène Feroce

This figure shows the co-authorship network connecting the top 25 collaborators of Irène Feroce. A scholar is included among the top collaborators of Irène Feroce based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Irène Feroce. Irène Feroce is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Serrano, Davide, Cristina Zanzottera, Francesca Fava, et al.. (2025). Hereditary Breast Cancer: Comprehensive Risk Assessment and Prevention Strategies. Genes. 16(1). 82–82. 1 indexed citations
2.
Fava, Francesca, Monica Marabelli, Mariarosaria Calvello, et al.. (2025). MLH1 promoter hypermethylation and Lynch Syndrome: When to test for constitutional epimutations of MLH1 gene?. Tumori Journal. 3887655698–3887655698. 1 indexed citations
3.
Polidoro, Silvia, Harriet Johansson, Giovanni Cugliari, et al.. (2025). Impact of Epigenome-Wide Methylation and Breast Cancer Recurrence in Women Tested Negative for BRCA Genes: The Breast Methylation Risk (BREMERI) Study. Cancers. 17(19). 3132–3132.
4.
Corso, Giovanni, Monica Marabelli, Mariarosaria Calvello, et al.. (2023). Germline pathogenic variants in metaplastic breast cancer patients and the emerging role of the BRCA1 gene. European Journal of Human Genetics. 31(11). 1275–1282. 8 indexed citations
5.
6.
Petrocchi, Serena, et al.. (2022). Psychological Determinants of Men’s Adherence to Cascade Screening for BRCA1/2. Current Oncology. 29(4). 2490–2503. 6 indexed citations
7.
8.
Marabelli, Monica, Sara Gandini, Mariarosaria Calvello, et al.. (2020). Is tumor testing efficiency for Lynch syndrome different in rectal and colon cancer?. Digestive and Liver Disease. 52(12). 1503–1511. 1 indexed citations
9.
Paneque, Milena, Ramona Moldovan, Christophe Cordier, et al.. (2017). The perceived impact of the European registration system for genetic counsellors and nurses. European Journal of Human Genetics. 25(9). 1075–1077. 8 indexed citations
10.
Feroce, Irène, Davide Serrano, Roberto Biffi, et al.. (2017). Hereditary diffuse gastric cancer in two families: A case report. Oncology Letters. 14(2). 1671–1674. 8 indexed citations
11.
Catania, Chiara, Irène Feroce, Monica Barile, et al.. (2015). Improved health perception after genetic counselling for women at high risk of breast and/or ovarian cancer: construction of new questionnaires—an Italian exploratory study. Journal of Cancer Research and Clinical Oncology. 142(3). 633–648. 6 indexed citations
12.
Paneque, Milena, Ramona Moldovan, Christophe Cordier, et al.. (2015). Development of a registration system for genetic counsellors and nurses in health-care services in Europe. European Journal of Human Genetics. 24(3). 312–314. 22 indexed citations
13.
Gandini, Sara, Irène Feroce, Aliana Guerrieri‐Gonzaga, et al.. (2015). Difficult choices for young patients with cancer: the supportive role of decisional counseling. Supportive Care in Cancer. 23(12). 3555–3562. 18 indexed citations
14.
Corso, Giovanni, Joana Figueiredo, Roberto Biffi, et al.. (2014). E-cadherin germline mutation carriers: clinical management and genetic implications. Cancer and Metastasis Reviews. 33(4). 1081–1094. 28 indexed citations
15.
Serrano, Davide, Matteo Lazzeroni, Sara Gandini, et al.. (2013). A randomized phase II presurgical trial of weekly low-dose tamoxifen versus raloxifene versus placebo in premenopausal women with estrogen receptor-positive breast cancer. Breast Cancer Research. 15(3). R47–R47. 22 indexed citations
16.
Fumagalli, Caterina, Giancarlo Pruneri, Michela Manzotti, et al.. (2012). Methylation of O 6-methylguanine-DNA methyltransferase (MGMT) promoter gene in triple-negative breast cancer patients. Breast Cancer Research and Treatment. 134(1). 131–137. 31 indexed citations
17.
Cazzaniga, Massimiliano, et al.. (2012). Fenretinide (4-HPR): A Preventive Chance for Women at Genetic and Familial Risk?. SHILAP Revista de lepidopterología. 2012. 1–9. 27 indexed citations
18.
Lazzeroni, Matteo, Aliana Guerrieri‐Gonzaga, Davide Serrano, et al.. (2010). Budesonide versus placebo in high-risk population with screen-detected lung nodules: Rationale, design and methodology. Contemporary Clinical Trials. 31(6). 612–619. 8 indexed citations
19.
Iodice, Simona, Monica Barile, Nicole Rotmensz, et al.. (2010). Oral contraceptive use and breast or ovarian cancer risk in BRCA1/2 carriers: A meta-analysis. European Journal of Cancer. 46(12). 2275–2284. 152 indexed citations
20.
Serrano, Davide, Luigi Mariani, Serena Mora, et al.. (2006). Quality of life assessment in a chemoprevention trial: Fenretinide and oral or transdermal HRT. Maturitas. 55(1). 69–75. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jeanna McCuaig Breakdown of academic impact, for papers by Luna Kaduri Breakdown of academic impact, for papers by Ingrid Slade Breakdown of academic impact, for papers by Rochelle Demsky Breakdown of academic impact, for papers by Kristen J. Vogel Breakdown of academic impact, for papers by Robin A. Lacour Breakdown of academic impact, for papers by Michaela Onstad Breakdown of academic impact, for papers by Douglas F. Easton Breakdown of academic impact, for papers by M. Daly Breakdown of academic impact, for papers by Simona Moroni
Rankless by CCL
2026